The nature of SARS-CoV-2 testing has changed. Where antibody tests were once chiefly used for charting the spread of infection within communities, today it is emerging as a key pillar of large-scale immunisation campaigns.

This webinar will present new data demonstrating the key roles antibody testing has to play. The data will foster discussions on understanding longevity of immunity and provide the opportunity to examine the rationale of pre-screening people for antibodies prior to vaccination.